Article
LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium
30 Jan 2024
Abstract excerpt
ABSTRACT Daptomycin (DAP) is often used as a first-line therapy to treat vancomycin-resistant Enterococcus faecium infections, but emergence of DAP non-susceptibility threatens the effectiveness of this antibiotic. Moreover, current methods to determine DAP minimum inhibitory concentrations (MICs) have poor reproducibility and accuracy. In enterococci, DAP resistance is mediated by the LiaFSR cell membrane stress...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
